CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $15.00 | $1.5M | 441,297 |
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $16.00 | $1.6M | 341,297 |
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −200,000 | 100,000 | ||
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Option exercise | +200,000 | $8.77 | $1.8M | 541,297 |
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $13.00 | $1.3M | 441,297 |
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $14.00 | $1.4M | 341,297 |
| 2018-09-25 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −200,000 | 300,000 | ||
| 2018-09-24 | Zakrzewski Joseph S Director | Option exercise | +500,000 | $3.40 | $1.7M | 726,047 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −407,251 | $10.30 | $4.2M | 318,796 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −26,949 | $11.23 | $303K | 291,847 |
| 2018-09-24 | Zakrzewski Joseph S Director | Sale | −65,800 | $12.18 | $801K | 226,047 |
| 2018-09-24 | Zakrzewski Joseph S Director | Option exercise · Stock Option (Right to Buy) | −500,000 | 1,050,000 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +20,834 | $1.40 | $29K | 421,307 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +158,334 | $2.50 | $396K | 579,641 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +112,500 | $2.50 | $281K | 692,141 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +142,500 | $2.50 | $356K | 834,641 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +52,147 | $2.95 | $154K | 886,788 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +33,750 | $8.10 | $273K | 920,538 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise | +100,000 | $8.77 | $877K | 1,020,538 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Sale | −529,791 | $10.04 | $5.3M | 490,747 |
Page 82 of 95 · 1,885 trades